Interview: Ferring Forges Ahead With mAbs For Reproductive Meds
Executive Summary
Antibody-based therapies have not really been investigated in the area of reproductive medicine and women’s health but Ferring is investing heavily to explore their potential, head of global pharmaceutical R&D Armin Metzger tells Scrip.